Tuesday, December 22, 2015
Samsung's Big Biotechnology Push in Songdo
As reported widely in the press, including The Wall Street Journal, the third production plant for which groundbreaking was held yesterday will be the world's single largest biologic drug plant (measured by production capacity) when completed in 2018. As shown in the accompanying graphic (click for a larger version), Samsung intends to become the world's largest contract biologic drug maker by 2020.
What I found most interesting about President Park Geun-hye's speech was how she noted the convergence of IT with biotechnologies and how this relates to her signature creative economy initiative.